Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S J Mathew

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
The American Journal of Psychiatry|June 1, 2001
PANDAS variant and body dysmorphic disorderS J Mathew
Journal of Psychiatric Practice|July 2, 2005
Biological therapies for obsessive-compulsive disorderB A Fallon, S J Mathew
Journal of Applied Physiology: Respiratory, Environmental and Exercise Physiology|July 1, 1983
Pulmonary vascular carbonic anhydrase activityA Bidani, S J Mathew, E D Crandall
Psychopharmacology Bulletin|October 26, 2002
Management of treatment-refractory panic disorderS J Mathew, J D Coplan, J M Gorman
The American Journal of Psychiatry|October 2, 2001
Neurobiological mechanisms of social anxiety disorderS J Mathew, J D Coplan, J M Gorman
The Journal of Neuropsychiatry and Clinical Neurosciences|May 20, 1999
Attitudes toward neurosurgical procedures for Parkinson's disease and obsessive-compulsive disorderS J Mathew, S C Yudofsky, L B McCullough, et al.
The Journal of Clinical Investigation|October 1, 1981
Effects of inhibition of RBC HCO3-/Cl- exchange on CO2 excretion and downstream pH disequilibrium in isolated rat lungsE D Crandall, S J Mathew, R S Fleischer, et al.
Drug and Alcohol Dependence|February 1, 2014
Therapeutic infusions of ketamine: do the psychoactive effects matter?E Dakwar, C Anerella, C L Hart, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 20, 2016
Balancing the Promise and Risks of Ketamine Treatment for Mood DisordersG Sanacora, H Heimer, D Hartman, et al.
CNS Spectrums|December 2, 2004
Glutamate-hypothalamic-pituitary-adrenal axis interactions: implications for mood and anxiety disordersS J Mathew, J D Coplan, D D Schoepp, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
The American Journal of Psychiatry|June 1, 2001
PANDAS variant and body dysmorphic disorderS J Mathew
Journal of Psychiatric Practice|July 2, 2005
Biological therapies for obsessive-compulsive disorderB A Fallon, S J Mathew
Journal of Applied Physiology: Respiratory, Environmental and Exercise Physiology|July 1, 1983
Pulmonary vascular carbonic anhydrase activityA Bidani, S J Mathew, E D Crandall
Psychopharmacology Bulletin|October 26, 2002
Management of treatment-refractory panic disorderS J Mathew, J D Coplan, J M Gorman
The American Journal of Psychiatry|October 2, 2001
Neurobiological mechanisms of social anxiety disorderS J Mathew, J D Coplan, J M Gorman
The Journal of Neuropsychiatry and Clinical Neurosciences|May 20, 1999
Attitudes toward neurosurgical procedures for Parkinson's disease and obsessive-compulsive disorderS J Mathew, S C Yudofsky, L B McCullough, et al.
The Journal of Clinical Investigation|October 1, 1981
Effects of inhibition of RBC HCO3-/Cl- exchange on CO2 excretion and downstream pH disequilibrium in isolated rat lungsE D Crandall, S J Mathew, R S Fleischer, et al.
Drug and Alcohol Dependence|February 1, 2014
Therapeutic infusions of ketamine: do the psychoactive effects matter?E Dakwar, C Anerella, C L Hart, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 20, 2016
Balancing the Promise and Risks of Ketamine Treatment for Mood DisordersG Sanacora, H Heimer, D Hartman, et al.
CNS Spectrums|December 2, 2004
Glutamate-hypothalamic-pituitary-adrenal axis interactions: implications for mood and anxiety disordersS J Mathew, J D Coplan, D D Schoepp, et al.
Pageof 2